TCOV
RCEL icon

Trust Company of Vermont’s Avita Medical RCEL Stock Holding History

Trust Company of Vermont’s Portfolio RCEL Stock Details RCEL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-195
Closed -$1K – 956
2022
Q3 		$1K Hold
195
– – ﹤0.01% 952
2022
Q2 		$1K Buy
+195
New +$1.21K ﹤0.01% 880
2022
Q1 		– Sell
-195
Closed -$2K – 643
2021
Q4 		$2K Buy
+195
New +$2.97K ﹤0.01% 778
2021
Q3 		– Sell
-195
Closed -$4K – 615
2021
Q2 		$4K Hold
195
– – ﹤0.01% 712
2021
Q1 		$4K Hold
195
– – ﹤0.01% 687
2020
Q4 		$4K Hold
195
– – ﹤0.01% 697
2020
Q3 		$5K Buy
+195
New +$4.86K ﹤0.01% 669

Other funds holding RCEL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PVI
Pura Vida Investments New York $14.9M AUM 38.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Trust Company of Vermont's RCEL Position: Q4 2022 in Review

Trust Company of Vermont sold out of Avita Medical (RCEL) in Q4 2022, closing a stake of 195 shares — an estimated $1K sold.

Trust Company of Vermont first reported a position in RCEL in Q3 2020 and held it in 7 quarters. The position peaked at $5K in Q3 2020. 52 funds tracked by Wall St. Rank hold RCEL as of Q4 2022.

  • Trust Company of Vermont reported no remaining Avita Medical position as of Q4 2022 after selling out during the quarter.
  • Trust Company of Vermont sold 195 Avita Medical shares in Q4 2022, an estimated $1K.
  • Trust Company of Vermont first reported a position in Avita Medical in Q3 2020 and held it in 7 quarters.
  • Trust Company of Vermont's Avita Medical position peaked at $5K in Q3 2020.
  • 52 funds tracked by Wall St. Rank held Avita Medical as of Q4 2022.

Based on Trust Company of Vermont's 13F filing for Q4 2022, filed 9 Feb 2023.